Enhancing the drug metabolism activities of C3A--a human hepatocyte cell line--by tissue engineering within alginate scaffolds.

In this study, we investigated the applicability of C3A--a human hepatocyte cell line--as a predicting tool for drug metabolism by applying tissue-engineering methods. Cultivation of C3A cells within alginate scaffolds induced the formation of spheroids with enhanced drug metabolism activities compared to that of two-dimensional (2-D) monolayer cultures. The spheroid formation process was demonstrated via histology, immunohistochemistry, and transmission electron microscope (TEM) analyses. The C3A spheroids displayed multilayer cell morphology, characterized by a large number of tight junctions, polar cells, and bile canaliculi, similar to spheroids of primary hepatocytes. Spheroid formation was accompanied by a reduction in P-glycoprotein (Pgp) gene expression and C3A cell proliferation was limited mainly to cells on the spheroid outskirt. The 3-D constructs maintained a nearly constant cell number according to MTT assay. Drug metabolism by the two most important cytochrome p-450 (CYP) enzymes in human liver, CYP1A2 and CYP3A4, was tested using preferred drugs. With CYP1A2, 3-fold enhancement in activity per cell was seen for converting ethoxyresorufin to resorufin compared to C3A cell monolayers. The spheroids responded to the inducer beta-naphthoflavone and to the inhibitor furafylline of CYP1A2. Enhanced metabolizing activity of CYP3A4, measured by the amount 6beta-testosterone formed from testosterone, and that of the phase II enzyme glucuronosyltransferases (UGT) further indicated that the tissue-engineered C3A spheroids may provide an efficient experimental tool for predicting drug activities by these CYPs. Moreover, the maintenance of constant cell number, as well as the elevated hepatocellular functions and drug metabolism activities, suggest that the tissue-engineered C3A may be applicable in replacement therapies.

[1]  Neil Kaplowitz,et al.  Liver biology and pathobiology , 2006, Hepatology.

[2]  Smadar Cohen,et al.  Ultrastructural and functional investigations of adult hepatocyte spheroids during in vitro cultivation. , 2004, Tissue engineering.

[3]  C. Philibert,et al.  Liquid chromatographic-mass spectrometric method to assess cytochrome P450-mediated metabolism of testosterone by rat everted gut sacs. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  K. Brouwer,et al.  P-glycoprotein Expression, Localization, and Function in Sandwich-Cultured Primary Rat and Human Hepatocytes: Relevance to the Hepatobiliary Disposition of a Model Opioid Peptide , 2004, Pharmaceutical Research.

[5]  Smadar Cohen,et al.  Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions , 2004, Biotechnology and bioengineering.

[6]  Smadar Cohen,et al.  Liver tissue engineering within alginate scaffolds: effects of cell-seeding density on hepatocyte viability, morphology, and function. , 2003, Tissue engineering.

[7]  S. Wilkening,et al.  Influence of culture time on the expression of drug‐metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2 , 2003, Journal of biochemical and molecular toxicology.

[8]  Smadar Cohen,et al.  Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication. , 2002, Biomaterials.

[9]  N. Sussman,et al.  A Fluorescent Cell-Based Assay for Cytochrome P-450 Isozyme 1A2 Induction and Inhibition , 2000, Journal of biomolecular screening.

[10]  J. Merchuk,et al.  Hepatocyte behavior within three-dimensional porous alginate scaffolds. , 2000, Biotechnology and bioengineering.

[11]  R. Hughes,et al.  Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure. , 1998, Artificial organs.

[12]  R. Cameron,et al.  Ethanol-induced apoptosis in vitro. , 1997, Clinical biochemistry.

[13]  L. Shapiro,et al.  Novel alginate sponges for cell culture and transplantation. , 1997, Biomaterials.

[14]  Roger Williams,et al.  Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure , 1996, Hepatology.

[15]  O. Moine,et al.  Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis , 1996, Hepatology.

[16]  A. Margeli,et al.  Proliferating cell nuclear antigen (PCNA) expression in regenerating rat liver after partial hepatectomy , 1994, Digestive Diseases and Sciences.

[17]  T. Goldsworthy,et al.  Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents. , 1993, Environmental health perspectives.

[18]  V. Dellarco,et al.  Genetic anomalies in mammalian germ cells and their significance for human reproductive and developmental risk. , 1993, Environmental health perspectives.

[19]  O. Fardel,et al.  Overexpression of the multidrug resistance gene product in adult rat hepatocytes during primary culture. , 1992, European journal of biochemistry.

[20]  G. Feldmann,et al.  Formation of plasma membrane domains in rat hepatocytes and hepatoma cell lines in culture. , 1988, Journal of cell science.